Title: Epidemiological and Clinical Feature of Newly Diagnosed Childhood Immune Thrombocytopenic Purpura in Qatar
Authors: Dr Budoor Kahtan Taha Al-Shammari MD, Shabina Khan MD, Rasha Qaqish MD, Yaslam Balfaqih MD, Yasmine Sobeih MD, Najla Ba Shaharil MD, Dr Ahmad Al-Hammadi, MD, FRCPC
DOI: https://dx.doi.org/10.18535/jmscr/v10i1.08
![](/jmscr/home/images/download_pdf_ijert.png)
Abstract
ITP (Immune thrombocytopenic purpura) is the most common bleeding disorder in childhood. It is usually a self-limiting disorder, and most patients recover spontaneously without serious complication. The clinical features of ITP have remained unchanged over the past few decades but there have been many recent changes in management strategies as evidenced by the new international guidelines on the management of childhood ITP. We wanted to study our pediatric inpatient population in Qatar who were admitted with acute ITP over the last 5 years for their presenting features and the management strategies adopted by our pediatricians. Most of these decisions in our institution are in conjunction with the pediatric hematology team. This study would also serve as baseline data, which could be used to compare changes in trends of management in the future.
References
- Rodeghiero F et al, Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood: 2009; 113:2386
- Management of Immune thrombocytopenic purpura: An update, Rajasekharan et al, Ochsner J. 2012 Fall; 12 (3): 221-227
- Tarantino M. The treatment of immune thrombocytopenic purpura in children.Curr Hematol Rep. 2006;5:89–94.
- Jadavji T, Scheifele D, Halperin S. Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J. 2003;22:119–122
- Immune Thrombocytopenic Purpura of Childhood, Diane Nugent, MD, Children’s Hospital of Orange County, American Society of Hematology Education Book, Jan 2006 vol 2006 no.1 (97-103)
- Mouzaki A, Theodoropoulou M, Gianakopoulos I, Vlaha V, Kyrtsonis MC, Maniatis A. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis. Blood.2002;100:1774–1779
- Lilleyman JS. Intracranial hemorrhage in idiopathic thrombocytopenic purpura.Arch Dis Child. 1994;71:251–3.
- Hospitalization of children with acute immune thrombocytopenic purpura-is it necessary? Paediatr Child Health. 2002 July-August; 7 (6): 386-389
- George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3–40
Corresponding Author
Dr Budoor Kahtan Taha Al-Shammari MD
Arab Board for Medical Specialties Pediatrics
Hamad Medical Corporation in Qatar